Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience

BACKGROUND: A national program for the treatment of severe allergic (IgE-dependent) asthma with omalizumab (OMA) was implemented in Poland in 2013. This observational study evaluated the effectiveness of the Polish OMA program and monitored asthma control after treatment discontinuation. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupryś-Lipińska, Izabela, Majak, Paweł, Molinska, Joanna, Kuna, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847261/
https://www.ncbi.nlm.nih.gov/pubmed/27117315
http://dx.doi.org/10.1186/s12890-016-0224-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847261/
https://www.ncbi.nlm.nih.gov/pubmed/27117315
http://dx.doi.org/10.1186/s12890-016-0224-2

Ejemplares similares